Georgios Manousakis
,
Credentials
MD

Associate Professor
Fellowship Director, Neuromuscular Medicine
Biography

Bio

I have been at the University of Minnesota since 2012, and Director of the Neuromuscular Medicine Fellowship Program since 2017. My priorities include offering exceptional clinical care for patients with neuromuscular diseases, providing the most up-to-date neuromuscular education to students, residents, and fellows, and researching new therapeutic options for neuromuscular conditions that represent unmet medical needs, with a specific focus on myopathies of adults and ALS.

Research Interests
Amyotrophic lateral sclerosis
Adult onset spinal muscular atrophy
Peripheral neuropathy
Neuromuscular junction disorders including myasthenia gravis
Muscular dystrophies of adults
Acquired myopathies of adults, including myositis

Clinical Summary

  • ALS Peripheral neuropathy
  • Neuromuscular junction disorders
  • Muscular dystrophies of adults
  • Acquired myopathies of adults

Education

MD, Magna cum laude, National and Kapodistrian University of Athens, Greece

Fellowships, Residencies, and Visiting Engagements

Fellow , Fellowship
Washington University
St. Louis, Missouri
Nerology Resident , Residency
University of Wisconsin Hospital and Clinics
Madison, Wisconsin
Internal Medicine-Preliminary Resident, Residency
Maimonides Medical Center
Brooklyn, New York

Licensures and Certifications

American Board of Psychiatry and Neurology, Certificate in Neuromuscular Medicine,
Licensure/Certification Number: 404
American Board of Psychiatry and Neurology, Certificate in Neurology,
Licensure/Certification Number: 56370
Clinical Neuromuscular Pathology, United Council for Neurologic Subspecialties

Honors and Recognition

A.B. Baker Teaching Award, American Academy of Neurology
2019
William Kennedy Teaching Award, University of Minnesota
2018
Top Doctors- Rising Stars, Minneapolis St Paul Magazine
2017
Top Doctors- Rising Stars, Minneapolis St Paul Magazine
2016
Top Doctors- Rising Stars, Minneapolis St Paul Magazine
2015
Selected Publications

Selected Publications

Cheong, I., Deelchand, D. K., Eberly, L. E., Marjańska, M., Manousakis, G., Guliani, G., Walk, D., Öz, G., 2019. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.. Journal of neurology, neurosurgery, and psychiatry, 90 (3): 294-301.
doi: https://doi.org/10.1136/jnnp-2018-318795 PubMed ID: 30467209.
McClelland, C., Manousakis, G., Lee, M. S., 2016. Progressive External Ophthalmoplegia.. Current neurology and neuroscience reports, 16 (6): 53.
doi: https://doi.org/10.1007/s11910-016-0652-7 PubMed ID: 27072953.
Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., Ostrow, L. W., Schoenfeld, D., Macklin, E. A., Norris, D. A., Manousakis, G., Crisp, M., Smith, R., Bennett, C. F., Bishop, K. M., Cudkowicz, M. E., 2013. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.. The Lancet. Neurology, 12 (5): 435-42.
Oczko-Walker, M., Manousakis, G., Wang, S., Malter, J. S., Waclawik, A. J., 2010. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.. Journal of clinical neuromuscular disease, 12 (2): 55-61.
Sattar, A., Manousakis, G., Jensen, M. B., 2010. Systematic review of reversible cerebral vasoconstriction syndrome.. Expert review of cardiovascular therapy, 8 (10): 1417-21.
doi: https://doi.org/10.1586/erc.10.124 PubMed ID: 20936928.
Contact

Contact

Address

12-138 PWB
420 Delaware Street SE
Minneapolis, MN 55455